arBtrage CAPITALIZING MARKETS checking… Sign in

Outlook Therapeutics, Inc.

OTLK Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$0.78
▼ -2.3% Today
as of Jun 7, 07:23 ET
Last 30 days +196.56% Apr 28 → Jun 05
$0.17 $0.35 $0.53 $0.71 $0.89 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$0.78
High
$0.85
Low
$0.73
Volume
$12M
Avg Vol
$7M
Mkt Cap
$89M
P/E (TTM)
Beta
52w High
$3.39
52w Low
$0.16
Div Yield
Shares Out
$105M

Overview

52-week range
$0.16
$3.39
19% of range
Avg surprise (last 2)
-3.0%
Avg reaction (last 2)
-3.1%
0% positive
Latest IV / EM
139%
EM ±19.3% · $1 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-8.01$-5.83$-3.64$-1.46$0.72 Actual $-1.61Actual $-0.86Actual $-8.01Actual $-0.89Actual $0.72Actual $-0.40Est $-0.55Actual $-0.55Actual $-0.38Actual $-0.16Est $-0.12 JunDecMarJunDecMar/2025JunDecMar/2026
Revenue vs Net Income Revenue Net income
$-46M$-23M$136,220$23M$47M Jun 24Dec 24Mar 25Jun 25Dec 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri May 15, 2026Mar/2026 $-0.16 $-0.12 -33.3% +60.0% -2.1% earnings
Wed Dec 31, 2025Dec 2025 $-0.38 financials
Mon Jun 30, 2025Jun 2025 $-0.55 financials
Thu May 15, 2025Mar/2025 $-0.40 $-0.55 +27.3% -4.0% earnings
Tue Dec 31, 2024Dec 2024 $0.72 financials
Sun Jun 30, 2024Jun 2024 $-0.89 financials
Sun Mar 31, 2024Mar 2024 $-8.01 financials
Sun Dec 31, 2023Dec 2023 $-0.86 financials
Fri Jun 30, 2023Jun 2023 $-1.61 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$149,327$29,626$439,815
Gross profit$-21,888$-1M$1M
Operating income$-14M$-13M$-16M$-12M$-22M$-20M
Net income$-4M$-23M$-20M$-46M$17M$44M
EPS (diluted)$-0.05$-0.38$-0.55$-1.50$0.72$-0.89

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$8M$9M$8M$9M$8M$6M$15M$32M
Inventory$3M$3M$3M$4M$4M$3M
Total current assets$21M$17M$17M$21M$18M$16M$27M$46M
Total assets$22M$18M$19M$22M$19M$17M$29M$47M
Long-term debt
Total liabilities$51M$57M$51M$60M$52M$67M$102M$131M
Total equity$-29M$-39M$-32M$-37M$-32M$-50M$-73M$-84M

Implied volatility — last 90 days

134%136%139%141%144% Jun 07 — IV 139% · EM ±19.3%

Sector peers